5. Introduction
• Technique by which heart tissue is sampled
from the patients with suspected cardiac
disorders for microscopic evaluation and
diagnosis of the lesions.
• Gold standard mode of investigation for
diagnosing cardiac diseases.
6. Historical aspects
• Open surgical biopsies of heart - 1950’s
Using Vim-silverman’s needle through
thoracotomy / trans-thoracic approach.
• 1st trans-venous biopsy –Bioptome in Japan in
1962
13. Procedure
• Performed through the transvascular
approach
• Right ventricle is preferred
-Easier and safer to biopsy
-Representative site in diffuse diseases.
• Left ventricle is preferred in sarcoidosis and
done via arterial approach
14. • A flexible, plastic tube called a “sheath” is
inserted into the vein in the neck or groin
• Insertion of “pulmonary artery catheter” into
the right side of heart
• Catheter is removed.
15. • Bioptome is guided through the sheath into
the heart.
• Biopsy forceps can easily be taken upto the
apical portion of Right ventricular septum.
• 3-4 tissue samples of 2-3 mm size are
obtained.
• Then the bioptome and sheath are removed.
16. • Flexible, disposable bioptomes- presently
available.
• Availability of catheters and bioptome forceps
of different sizes and designs
• Apical curvature- for easy sampling and grip
on the tissue.
19. Tissue Processing
• 4-5 biopsy fragments are processed routinely
and 1 fragment for EM exam.
• Transplant biopsies- if vascular rejection is
suspected, 1 fragment is frozen for
immunofluorescence.
• Anthracycline, Chloroquine and Amiodarone
toxicity- All fragments are processed for EM.
20. PROBLEMS DURING INTERPRETATION
• Sampling error-due to focal nature of disease
• Crush artifacts
• Contraction bands
• Focal interstitial fibrosis
22. Complications
• PERFORATION
– Chest pain and pericardial effusion as judged by
transthoracic echocardiography or TEE
• The risk of perforation can be reduced by
using a specially curved sheath to guide the
biopsy forceps toward the interventricular
septum.
23. • Air embolism
• Myocardial infarction
• Transmission of infections
• Damage to valves
• Chest pain, hematoma
• Arrythmias(AF/VF)
• Pneumothorax
• Haemopericardium
24. Cardiac transplantation
• Worldwide about 1 lakh adult and 11000
pediatric heart transplantation have been
performed
• Survival rate is 88% at 1st year,
80% at 2nd year
75% at 3rd year
29. Introduction
• Heterogeneous group of diseases
• Mechanical &/or electrical dysfunction
• Ventricular hypertrophy or dilatation
• Variety of causes that frequently are genetic.
• Cardiomyopathies either are confined to the
heart or are a part of generalized systemic
disorders
35. Incidence and prognosis
• Prevalence – 36/1,00,000
• 3rd most common cause of heart failure
• Most frequent cause of heart transplantation
• Complete recovery is rare
• 50% die within 2yrs
36. Causes
• Genetic
– Autosomal dominant
– Mutations in genes encoding dystrophin,δ
sarcoglycan, troponin T, β MHC etc
• Myocarditis
• Alcohol and other toxins
• Childbirth (peripartum cardiomyopathy)
37. Clinical features
• Peak incidence in middle age
• Symptoms may be gradual in onset
• Acute presentation
– Misdiagnosed as viral URI in young adults
43. Peripartum cardiomyopathy
• Four criteria: three clinical and one echocardiographic
1. Development of heart failure during last trimester
of pregnancy or first six months post partum.
2. Absence of any identifiable cause for cardiac failure.
3. Absence of any recognizable heart disease prior to
last trimester of pregnancy.
44. 4. Echocardiographic criteria - Demonstrable
proof of left ventricular systolic dysfunction.
- Ejection fraction less than 45%,
-Left ventricular end- diastolic dimension
>2.7cm/m square of body surface area.
46. • Most common genetic disorder of heart
• Prevalence : 1 in 500 adults
• Characterised by myocyte hypertrophy in the
absence of hypertension, stenotic valvular
disorder or infiltrative disorders
47. Pathogenesis
• Autosomal dominant
• Remaining are sporadic
• Mutations are mostly missense
• Mutations causing HCM found in genes
encoding β MHC, cardiac TnT, α tropomyosin,
myosin binding protein C
48. Pathophysiology
• Impaired diastolic filling
↓
reduced stroke volume
• Reduced CO and increase in pulmonary
venous pressure
↓
exertional dyspneoa
51. • Begins during early
adolescence and stops
when growth has
finished
• Left ventricle almost
always affected.
• Hypertrophy is usually
greatest in the septum
52. • Asymmetric septal
hypertrophy with obstruction
to the outflow of blood from
the heart may occur. The
mitral valve touches the
septum, blocking the outflow
tract. Some blood is leaking
back through the mitral valve
causing mitral regurgitation
57. Introduction
• Rigid ventricular wall with impaired
ventricular filling
• Contractile functions are normal
• Abnormal diastolic function
• Less common
59. Clinical manifestations
• Symptoms of right and left heart failure
• Echo-Doppler – Abnormal mitral inflow
pattern -Prominent E wave (rapid diastolic
filling)
• Almost invariably progresses to congestive
heart failure,10% survive for 10 yrs
60. Morphology
• Ventricles are of normal size
• Cavities are not dilated
• Myocardium is firm and non compliant
• Biatrial dilatation is common
• Patchy/diffuse interstitial fibrosis
61.
62.
63. Arrhythmogenic right ventricular
cardiomyopathy
• Inherited disease of cardiac muscle
• RVF, rhytm disturbances, ventricular
tachycardia, fibrillation
• Right ventricular wall is thinned, extensive
fatty infiltration and fibrosis
• Autosomal dominant inheritence
67. Morphology
• Ventricles - Normal to dilated
- thinned walls (DCM)
- thickened LV walls with small
chambers (HCM)
• Cut surface – waxy appearance
• Can also involve endocardium, myocardium,
pericardium, valves and vessels
68.
69. Pompe disease
• - deficiency of acid maltase
- Autosomal recessive
-hepatomegaly, failure to thrive, hypotonia,
macroglossia, massive cardiomegaly
- heart is enlarged and mimics HCM
70.
71. Fabry’s disease
• Storage disorder
• Deficiency of alpha galactosidase A enzyme
↓
Glycophospholipid accumulation
• X – linked disorder
• Ventricular hypertrophy, heart failure,
arrhythmia, conduction defects
72.
73. Hemochromatosis
• Mc inheritable metabolic disorder
• Prevalence 1:200-400
• Increased iron deposition in heart, liver, pituitary
gland, pancreas and skin.
• Autosomal recessive
• HFE- mc mutation
74.
75. Drug related cardiomyopathy
• Anthracyclin antibiotics- doxorubicin,
daunorubicin
• Precipitated by infection, pregnancy or
surgery
• Congestive heart failure, arrhythmia –
common
76. Microscopy
• Tissue is fixed and processed in glutaraldehyde
solution
• 10 plastic blocks is required for assessing
numerical grade
• One micron sections are cut and stained by
toluidine blue stain and assessed under light
microscopy for distribution and extent of cell
injury
77. • Myocytes appear shrunken with homogenous pale
cytoplasm and cytoplasmic vacuolization
79. Grading of chronic anthracycline
cardiotoxicity
• Grade 0 – normal ultrastructural appearance
of myocytes
• Grade 1.0 – isolated or scattered myocytes
showing sarcotubular distension or early
myofibrillar loss; damage to <5% of all cells
• Grade 1.5 – changes as grade 1 but involving
6%-15% of all cells
80. • Grade 2 – clusters of myocytes with
myofibrillary loss or sarcotubular distension
involving 16-25% of all cells
• Grade 2.5 – numerous damaged myocytes
(26-35%) showing characterised changes
• Grade 3 – diffuse/confluent myocyte damage
of >35% of cells, necrotic cells may be seen
83. Myocarditis
• Both inflammation and myocyte damage are
present.
• Depending on the composition of the cellular
infiltrate the specific type of myocarditis.
86. Hypersensitivity Myocarditis
• Most common form of acute drug-related
myocardial injury
• Antibiotics, diuretics, and antihypertensive
drugs
• Clinical signs : rash, fever, peripheral
eosinophilia, and occasionally arrhythmias,
sudden death, and congestive heart failure.
87. • The histopathologic features include uniform
lesions distributed in the subendocardial,
perivascular, and interstitial tissues between
bundles of myocytes.
88.
89. Toxic Myocarditis
• Uncommon
• Characterized by direct myocyte cytotoxicity.
• Causative agents - antineoplastic drugs
• The lesions are focal and temporally
heterogeneous.
90.
91. Sarcoidosis
• Cardiac involvement in sarcoidosis is 25% to
60%.
• Include classic noncaseating granulomatous
inflammation, lymphocytic myocarditis, DCM
and normal myocardium.
• Diffuse myocardial involvement progresses to
myocyte hypertrophy and interstitial fibrosis
resembling DCM
92. Gross
• Firm, white nodules
forming discrete masses
within the
interventricular septum,
LV free wall, or papillary
muscle
93.
94. Idiopathic giant cell myocarditis
• Rare
• Fatal form of myocarditis that occurs in
previously healthy young adults.
• Clinical onset is abrupt
• Characterized by rapidly progressive heart
failure and/or arrhythmias.
95. Morphology
• Multifocal areas of necrosis are easily
observed in the heart.
• The heart weight is normal or slightly
increased. All chambers of the heart are
uniformly involved in most cases.
98. References
• Sternberg, s diagnostic surgical pathology.
• Silverberg’s principle and practice of surgical
pathology and cytopathology.
• Cardiovascular pathology
• Journals on cardiovascular pathology
Bioptome – small pincer shaped cutting/grasping instrument
A novatome – 2-3mm tip, 9F sheath, single use
B argon endomyocardial forceps – 8mm tip that requires a 7-F sheath
C Bipal 7 bioptome, 50cm and 104cm – 2-3mm tip, 7F sheath
D 8 –F transseptal mullens sheath when using the longer Bipal 7 bioptome through right femoral vein access to improve tip control and placement
( under fluoroscopic guidance), which measures the pressures inside the heart.
1.
2(non specific finding)
3 (normal in rt ventr biopsy) 0- 1.3cm
10%
Fever, shortness of breath, new chest pain/ tenderness, increased BP
Cardiac allograft specimen,s are high and EMB is the gold standard for diagnosing acute transplant rejection
1990ISHLT SCHEME- international society for heart and lung transplantation
2004 revised ISHLT – 1A, 1B, 2 – mild rejectuion (1R)
3A – moderate rejection (2R)
3B, 4 – severe rejection (3R)
Acute cardiac rejection – ag-ab raection
Chronic rejection – blockage in intramural and epicardila vessels
No rejection (0)
Focal mild rejection (1A) : perivascular interstitial infiltrate without myocyte damage
Diffuse mild rejection (1B) : interstitial infiltrate without myocyte damage
Focal moderate (2) : solitary focus of infiltrate associated with myocyte damage
Multifoacl moderate rejection (3A) : 2/more foci of infiltrates associated with myocyte damage
Diffuse moderate rejection (3B) : diffuse, often polymorphous inflammatory infiltrates in many biopsy pieces with conspicuous myocyte damage
Severe rejection (4) : finding of 3B rejectioin + interstitial edema, hemorrhage +/- small vessel vasculitis
“a heterogeneous group of diseases of the myocardium associated with mechanical &/or electrical dysfunction that usually (but not invariably) exhibit inappropriate ventricular hypertrophy or dilatation and are due to a variety of causes that frequently are genetic.” Cardiomyopathies either are confined to the heart or are a part of generalized systemic disorders
Infiltrative (amyloidosis, gaucher’s
Storage disorder (fabry’s disease, glycogen storage, hemochromatosis )
Toxic/ drug / therapy related (anthracycline, cyclophosphamide)
Mc indication for cardiac transplantation
MHC- myosin heavy chain
Increased in weight, globular in shape, all chambers dilated, mural thrombi, endocardial fibrous thickrning over septrum of LV, reduced free wall thickness
Hypertrophic myocytes
Cytoplasmic vacuolations
Interstitium is expanded by collagen fibres – trichrome stain?
Lymphocytic infiltration at the interstsitium
- Ejection fraction less than 45%,
- left ventricular fractional shortening less than 30% or left ventricular end- diastolic dimension >2.7cm/m square of body surface area.
Short axis method of dissection
The major abnormality of the heart in HCM -- excessive thickening of the muscle
. Thickening usually begins during early adolescence and stops when growth has finished. uncommon for thickening to progress after this age left ventricle almost always affected. Hypertrophy is usually greatest in the septum, associated with obstruction to the flow of blood into the aorta
Extensive myocyte hypertrophy
Myocyte Disarray
Interstitial and replacement fibrosis
LVEDD : < 45 mm > 45 mm
Normal weight of heart, Ventricles are of normal size
Cavities are not dilated
Myocardium is firm and non compliant
Biatrial dilatation is common
Patchy/diffuse interstitial fibrosis
Myocyte hypertrophy, interstitial fibrosis
Interstitial fibrosis highlighted by trichrome stain
Characterized by deposition of IG light chain – poor prognosis
1. Most common type - immunoglobulin associated amyloidosis (AL type), Seen in primary amyloidosis, plasma cell dyscrasias
2. AD- mutation in transthyretin protein(TTR), transplantation is definitive traetment
3. Deposition of wild type transthyretin , occurs in middle and old men
• Amyloid deposition is most prominent in interstitial, perivascular and endocardial regions.
Pale, finely fibrillar eosinphilic ,material
Masson trichrome stain – distuinguishes from amyloid by gray –blue
Zeis medium / normal medium - fixation
Cardiac enlargement without ventricular dilatation • Ventricular walls are thickened and rubbery
• Amyloid deposition is most prominent in interstitial, perivascular and endocardial regions.
Pale, finely fibrillar eosinphilic ,material
Masson trichrome stain – distuinguishes from amyloid by gray –blue from collagen
Zeis medium / normal medium - fixation
Group of inherited enzymatic deficiencies for the synthesis or utilization of glycogen
12 types
Enlarged myocytes
Vacuolated cytoplasm
Cytoplasm filled with glycogen
To differentiate from vacuolization of normal myocytes – dis is uniformly massive and diffuse vacuolization
Marked LV hypertrophy mimics HCM both macroscopically and functionally.
In EMB sections, the myocytes and endothelial cells are diffusely vacuolated with pinpoint weakly positive predigested PAS granules within these spaces (Fig. 29.15). The diagnosis is confirmed at the ultrastructural
level by the presence of membrane-bound electron-dense lamellar myelin (“zebra”) bodies
HFE gene – chromosome 6
C282y, H63D
Dark brown granular deposition v/s lipofuchsin
Hematolymphoid malignancies, efficacy is limited due to cardiotoxicity
Shrunken bcoz of myofibrillary loss
Vacuoloization bcoz of sacrotubular dilatation
Retention of Z- band remnants
1 – therapy continues
1.5 – continued
2 – continues wid close cardiac assessment
2.5 – one more dose of anthracycline
3 - discontinued
The distribution of inflammatory infiltrate may be focal, confluent, or diffuse;
the severity ranges from mild to severe. The most difficult challenge is the determination of myocyte damage in the biopsy specimen. In our experience, florid myocytolysis and necrosis are not common biopsy patterns.
myocarditis (e.g., lymphocytic, eosinophilic, neutrophilic, giant cell, granulomatous, or mixed cell types).
The distribution of inflammatory infiltrate may be focal, confluent, or diffuse; the severity ranges from mild to severe. The most difficult challenge is the determination of myocyte damage in the biopsy specimen. In our experience, florid myocytolysis and necrosis are not common biopsy patterns.
mononuclear cells that encroaches into the sarcolemmal membrane of myocytes
Fragmentation of myocytes with remnants of cytoplasm or “bare nuclei,” architectural displacement or distortion of myocytes by inflammatory cells, or partial replacement of myocytes by inflammatory cells.
The predominant inflammatory cells are eosinophils, but variable numbers of histiocytes and scattered lymphocytes are also found.
Myocyte necrosis is absent.
No giant cells
The inflammatory infiltrates are polymorphous with lymphocytes, plasma cells, and neutrophils, but eosinophils are rare or absent.
Example is the acute form of doxorubicin cardiotoxicity presenting as acute myocarditis
The inflammatory infiltrates are polymorphous with lymphocytes, plasma cells, and neutrophils, but eosinophils are rare or absent.
Example is the acute form of doxorubicin cardiotoxicity presenting as acute myocarditis
Classic granulomatous pattern is characterized by
Tan white foci within myocardium
Discrete granuloma embedded in fibrous scar tissue
granulomas composed of epithelioid histiocytes and multinucleated giant cells arranged in round or oval aggregates. These can be found as isolated lesions or may coalesce to form larger zones within the myocardium. Endocardial and pericardial involvement is observed in some cases. Scattered around and within the granulomas are mature
The epithelioid histiocytes express CD68, and the infiltrating lymphocytes are almost exclusively T cells with a predominance of CD4+
cells
lymphocytes, but eosinophils are absent or sparse in number. Mature collagenous fibrosis is present and surrounds the granulomas, but active myocyte
necrosis is uncommon.
. Death occurs within weeks or months of onset of symptoms unless aggressive immunosuppression and cardiac transplantation are implemented
20% of patients have an associated autoimmune disorder such as ulcerative colitis, cryofibrinogenemia, rheumatoid arthritis, myasthenia gravis, hyperthyroidism, and hypothyroidism
Active/ acute phase : Widespread myocyte dmage which is replaced by mixed inflammatory cells
Multinucleate giant cell, lympho, eosino, histiocytes
Healed / resolved phase : Trichrome stain-healed idiopathic giant cell myocarditis with outer half of myocardium replaced by mature collagen